Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Virtual Reality-Supported Child Abuse and Body Safety Education for Nursing Students (VR-BodySafe)

12 novembre 2026 mis à jour par: Edanur Tar Bolacali, Kirsehir Ahi Evran Universitesi

The Effect of Virtual Reality-Supported Child Abuse and Body Safety Education for Nursing Students on Awareness, Diagnosis and Reporting Attitudes: A Randomized Controlled Trial

The goal of this randomized controlled trial is to learn whether a virtual reality-supported child abuse and body safety education program improves fourth-year nursing students' awareness of child abuse and neglect, their ability to recognize its signs and risk factors, and their attitudes toward reporting it. The main questions it aims to answer are: - Do students who receive the program score higher in recognizing the signs and risks of child abuse and neglect than students who do not? - Do they have higher awareness of child abuse and neglect and more positive attitudes toward reporting child abuse? - Are these effects still present one month after the program ends? Researchers will compare an intervention group, which takes part in an 8-week face-to-face program (one 90-minute session per week) ending with a virtual reality simulation, with a control group that receives no training during the study. Control group students will be offered the same training after the study ends. Participants will: - Complete questionnaires before the program, after the program, and one month later - If assigned to the intervention group, attend weekly education sessions and take part in a short virtual reality simulation in week 8

Aperçu de l'étude

Statut

Pas encore de recrutement

Les conditions

Intervention / Traitement

Description détaillée

Background: Nurses are often the first health professionals to see signs of child abuse and neglect, but nursing students report limited knowledge, limited clinical exposure and uncertainty about legal reporting duties. Technology-based and simulation-based education may help close this gap. Design and setting: Two-arm, parallel-group, pretest-posttest randomized controlled trial with a one-month follow-up, conducted at the Department of Nursing, Faculty of Health Sciences, Kirsehir Ahi Evran University, Kirsehir, Turkiye. The study was approved by the Cankiri Karatekin University Health Sciences Ethics Committee (Meeting No. 33, 12 May 2026) and is funded by the Kirsehir Ahi Evran University Scientific Research Projects Coordination Unit (SYO.A3.26.006). Reporting will follow the CONSORT 2025 statement. Sample size: Calculated with G*Power 3.1.9.2 using Child Abuse and Neglect Symptoms and Risk Diagnosis Scale scores from a similar study (3.39 +/- 0.28 and 3.60 +/- 0.28; effect size 0.75, alpha 0.05, power 0.95), giving 96 students (48 per group). Allowing for attrition, 100 students (50 per group) will be enrolled. Randomization and allocation concealment: After baseline measurements, students will be assigned 1:1 to the intervention or control group by simple randomization using a computer-generated sequence (randomizer.org). Randomization will be performed by an independent researcher not involved in delivering the intervention, and the allocation list will be concealed from the research team until assignment. Masking: Because of the nature of the intervention, participants and educators cannot be masked. Data will be coded (e.g., Group A and Group B) and analyzed by an independent statistician unaware of group allocation. Intervention delivery: Seven weekly face-to-face modules use active learning techniques. In week 8, students take part in the virtual reality game "Look From My World", in which they experience, from a 7-year-old child's point of view, a child's attempt to disclose a body safety violation to a school nurse and compare an inappropriate and an appropriate nursing response. The scenario does not depict abuse. A structured PEARLS debriefing follows. Module content and the scenario were reviewed by experts and will be pilot-tested with nursing students before the trial. Data analysis: IBM SPSS Statistics 29.0. Group x time effects will be tested with two-way repeated measures ANOVA when parametric assumptions are met, or with non-parametric equivalents. Analysis will follow the intention-to-treat principle. The significance level is set at p < 0.05. Safety: Participants may stop the virtual reality application at any time without any consequence. Students with epilepsy or severe motion sickness are excluded. Psychological support and referral information are available during and after the sessions.

Type d'étude

Interventionnel

Inscription (Estimé)

100

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans et plus (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Oui

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • Fourth-year student at the Department of Nursing, Faculty of Health Sciences, Kirsehir Ahi Evran University
  • Has completed the Child Health and Diseases Nursing (Pediatric Nursing) course
  • Has not previously attended a structured education program on child abuse and body safety
  • Volunteers to participate and signs the informed consent form
  • States that they can attend the education sessions and all measurements

Exclusion Criteria:

  • Has received certified training in child abuse, neglect or forensic nursing
  • Is actively working in an institution or project related to child abuse
  • Has a known health condition that may prevent virtual reality use (e.g., severe motion sickness or vertigo, epilepsy)
  • Did not complete the baseline measurements or completed the scales with substantial missing or invalid responses

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Autre
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Aucun (étiquette ouverte)

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: VR-Supported Body Safety Education

Fourth-year nursing students who receive an 8-week face-to-face education program (one 90-minute session per week) on child abuse, neglect and body safety, ending with a virtual reality simulation in week 8.

An 8-week face-to-face program with one 90-minute session per week. Weeks 1-7 cover child maltreatment; child neglect and the nursing approach; types of child abuse (physical, emotional, sexual and cyber abuse); child abuse and the nursing approach, including documentation and legal reporting; interventions for preventing child abuse and neglect; and body safety education for teaching children self-protection skills (two sessions). Each module uses an active learning technique (station technique, six thinking hats, brainstorming, six action shoes, cooperative learning). In week 8, students complete the virtual reality game "Look From My World" (about 6 minutes), experiencing from a 7-year-old child's perspective a disclosure to a school nurse with an inappropriate and an appropriate nursing response, followed by a structured PEARLS debriefing.

Aucune intervention: Wait-list Control

Fourth-year nursing students who receive no training during the study and continue their usual curriculum. They will be offered the same program after the one-month follow-up measurement.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Recognition of Signs and Risks of Child Abuse and Neglect
Délai: Baseline (before randomization), post-intervention (within 1 week after week 8), and 1 month after the end of the intervention

Measured with the Child Abuse and Neglect Symptoms and Risk Diagnosis Scale (Uysal, 1998), 67 items in 6 subscales rated on a 5-point Likert scale (21 items reverse-scored). Total score ranges from 67 to 335; higher scores indicate better recognition of the signs and risk factors of child abuse and neglect.

Baseline (before randomization), post-intervention (within 1 week after week 8), and 1 month after the end of the intervention

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Child Abuse and Neglect Awareness
Délai: Baseline (before randomization), post-intervention (within 1 week after week 8), and 1 month after the end of the intervention

Measured with the Child Abuse and Neglect Awareness Scale, 20 case-based items in 4 subscales (physical, sexual and emotional abuse, and neglect) rated on a 5-point Likert scale. Total score ranges from 20 to 100; higher scores indicate greater awareness of child abuse and neglect.

Baseline (before randomization), post-intervention (within 1 week after week 8), and 1 month after the end of the intervention
Attitudes Toward Reporting Child Abuse
Délai: Baseline (before randomization), post-intervention (within 1 week after week 8), and 1 month after the end of the intervention

Measured with the Turkish version of the Healthcare Provider Attitudes Toward Child Maltreatment Reporting Scale (Singh et al., 2017; Turkish adaptation by Turan and Erdogan, 2019), 21 items rated on a 5-point Likert scale. Total score ranges from 21 to 105; higher scores indicate more positive, responsibility-oriented attitudes toward reporting child abuse.

Baseline (before randomization), post-intervention (within 1 week after week 8), and 1 month after the end of the intervention

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Parrainer

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Publications générales

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Estimé)

17 novembre 2026

Achèvement primaire (Estimé)

15 janvier 2027

Achèvement de l'étude (Estimé)

28 février 2027

Dates d'inscription aux études

Première soumission

12 novembre 2026

Première soumission répondant aux critères de contrôle qualité

12 novembre 2026

Première publication (Réel)

18 novembre 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

18 novembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

12 novembre 2026

Dernière vérification

1 novembre 2026

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • SYO.A3.26.006

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Description du régime IPD

Individual participant data will not be shared because participants did not consent to data sharing and the dataset includes sensitive information about participants' own childhood experiences of abuse and neglect. Aggregate results will be published in a peer-reviewed journal.

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .